dengue virus
Showing 1 - 14 of 14
Dengue Disease, Dengue Virus Trial (V181 High-Potency Level, V181 Mid-Potency Level, V181 Low-Potency Level)
Not yet recruiting
- Dengue Disease
- Dengue Virus
- V181 High-Potency Level
- +3 more
- (no location specified)
Aug 17, 2022
Dengue Virus, Dengue Fever, Dengue Hemorrhagic Fever Trial in Long Xuyên (CYD dengue vaccine serotypes (1, 2, 3, 4).,
Completed
- Dengue Virus
- +3 more
- CYD dengue vaccine serotypes (1, 2, 3, 4).
- Meningococcal Polysaccharide A+C; NaCl; Typhoid Vi polysaccharide
-
Long Xuyên, An Giang Province, VietnamSanofi Pasteur Investigational Site
Mar 15, 2022
Dengue Virus, Dengue Fever, Dengue Hemorrhagic Fever Trial in Chulucanas Morropon (CYD Dengue Vaccine Serotypes 1, 2, 3, and 4,
Completed
- Dengue Virus
- +3 more
- CYD Dengue Vaccine Serotypes 1, 2, 3, and 4
- Pneumococcal polysaccharide vaccine
-
Chulucanas Morropon, Piura, Peru(unnamed)
Mar 10, 2022
Dengue Virus, Dengue Fever, Dengue Hemorrhagic Fever Trial in Bangkok (CYD Dengue Vaccine, Inactivated rabies virus vaccine,
Completed
- Dengue Virus
- +3 more
- CYD Dengue Vaccine
- +2 more
-
Bangkok, ThailandSanofi Pasteur Investigational Site
Mar 10, 2022
Dengue, Dengue Hemorrhagic Fever, Dengue Virus Trial in Worldwide (CYD Dengue Vaccine, Tetanus Toxoid Reduced Diphtheria Toxoid
Completed
- Dengue
- +3 more
- CYD Dengue Vaccine
- Tetanus Toxoid Reduced Diphtheria Toxoid Acellular Pertussis
-
Bucaramanga, Colombia
- +3 more
Mar 15, 2022
Dengue Fever, Dengue Hemorrhagic Fever, Dengue Virus Trial in Singapore (CYD Dengue vaccine, NaCl + influenza virus or hepatitis
Completed
- Dengue Fever
- +3 more
- CYD Dengue vaccine
- NaCl + influenza virus or hepatitis A vaccine
-
Singapore, Singapore
- +4 more
Mar 10, 2022
Dengue Virus Trial in Silver Spring (TDENV-PIV, TDENV-LAV F17)
Active, not recruiting
- Dengue Virus
- TDENV-PIV
- TDENV-LAV F17
-
Silver Spring, MarylandWRAIR, Clinical Trials Center
Mar 25, 2021
Dengue Fever, Dengue Hemorrhagic Fever, Dengue Virus Trial in United States (Tetravalent CYD Dengue Vaccine , 5555 formulation,
Completed
- Dengue Fever
- +2 more
- Tetravalent CYD Dengue Vaccine , 5555 formulation
- +2 more
-
Hoover, Alabama
- +4 more
May 21, 2019
Arbovirus Infections in Deferred Blood Donors (ZVADD)
Completed
- Zika Virus
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Mar 15, 2019
A Prospective, Open Label, Treatment Use Study of Patient Safety
Completed
- Chikungunya Virus
- Dengue Virus
- INTERCEPT Platelets
-
Aibonito, Puerto Rico
- +7 more
Jan 24, 2018
Dengue, Dengue Fever, Dengue Hemorrhagic Fever Trial in Adelaide (Chimeric dengue serotype (1, 2, 3, 4))
Completed
- Dengue
- +3 more
- Chimeric dengue serotype (1, 2, 3, 4)
-
Adelaide, Australia(unnamed)
Feb 23, 2018
Dengue Virus, Dengue Fever, Dengue Hemorrhagic Fever Trial in Tlalpan, Valle de Chalco (Bivalent CYD-1,3 Dengue (Vero) +
Completed
- Dengue Virus
- +3 more
- Bivalent CYD-1,3 Dengue (Vero) + Bivalent CYD-2,4 Dengue (Vero)
- +3 more
-
Tlalpan, Mexico
- +1 more
Mar 2, 2015
Dengue Virus Trial in Burlington (Investigational Vaccine for DEN1, Placebo injection)
Completed
- Dengue Virus
- Investigational Vaccine for DEN1
- Placebo injection
-
Burlington, Vermont
- +1 more
Dec 31, 2012
Dengue Virus Trial in Washington (Investigational Vaccine for Dengue Virus Subtype 2, Placebo)
Completed
- Dengue Virus
- Investigational Vaccine for Dengue Virus Subtype 2
- Placebo
-
Washington, District of ColumbiaJohns Hopkins Project SAVE, Center for Immunization Research
Dec 31, 2012